DexCom, Inc. (DXCM) - Episode 59 - Sep 22, 2025

They say what goes up must come down, but for DexCom, the descent has been a dramatic, cable-cutting freefall. In this episode of D-Risk, we dissect the 11% plunge in medical device maker DXCM, triggered by a bombshell investigative report and a CEO's medical leave. We uncover a stark conflict: Wall Street analysts remain stubbornly bullish, while the market is in full-blown panic mode, and our analysis reveals the stock was already overvalued. With bearish sentiment flooding the options market and a clear technical breakdown, we'll determine if this drop is a disaster or a deeply discounted opportunity. You'll hear our final verdict and the critical levels to watch to see if this falling knife is too dangerous to catch.    

There are no comments yet.

Please log in to write the first comment.